In October 2020 the Brazilian Doping Control Authority (ABCD) reported an anti-doping rule violation against the football player after his A and B samples tested positive for the prohibited substance Isometheptene.
After notification the Athlete filed a statement in his defence and the case was referred to the Brazilian Sports Justice Anti-Doping Tribunal (TJD-AD).
The Athlete declined an acceptance of sanction of 6 months proposed by ABCD, accepted the test results and denied the intentional use of the substance. He requested for a reduced sanction due to No Significant Fault or Negligence.
He asserted that the source of the prohibited substance was an unprescribed medication Doralgin he had used for his headache. The Brazil Lab confirmed that the positive test result was consistent with the Athlete’s use of this medication.
The TJD-AD Rapporteur finds that the presence of a prohibited substance has been established in the Athlete’s samples and accordingly that he committed an anti-doping rule violation.
The Rapporteur accepts that the violation was not intentional and that there are grounds for a reduced sanction in view of the Athlete’s degree of fault. Further the Rapporteur considers that in similar cases reduced sanctions were imposed by the TJD-AD and that there were delays in the proceedings not attributed to the Athlete.
Therefore the TJD-AD Panel dedices on 22 April 2021 to impose a 12 month period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 1 September 2020.